Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating obesity with at least one weight-related comorbidity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Obesity or Overweight | Phase 2 | Status: COMPLETED